Clinical trial

Effects of InFat™ Product on Stool Biochemistry and Stool Characteristics in…

NCT00480948 · Enzymotec, Industry · Terminated

Key facts

NCT number NCT00480948
Title Effects of InFat™ Product on Stool Biochemistry and Stool Characteristics in Formula-fed Term Chinese Infants
Official title Effects of InFat™ Product (High Sn-2 Palmitic Acid) on Stool Biochemistry and Stool Characteristics in Formula-fed Term Chinese Infants: a Triple-blind, Randomized, Placebo-controlled Trial
Lead sponsor Enzymotec, Industry
Status Terminated
Phase Phase 4
Study type Interventional
Conditions Healthy
Intervention type Behavioral, Dietary Supplement
Interventions Infant formula feeding (InFat™), Control
Enrollment 80
Start date Sep 1, 2008
Primary completion Apr 1, 2009
Completion Aug 1, 2009
First posted May 31, 2007
Last update posted Jun 7, 2011
Countries China

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies